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Objectives: Epstein Barr virus (EBV)-transformed lymphoblastoid cell lines (LCLs)
are a useful biological resource, however, genomic variations can happen during
the generation and immortalization processes of LCLs. The purpose of this study
was to identify genomic variations in LCL DNA compared with matched blood DNA
using short tandem repeats (STRs) analysis.
Methods: We analyzed 15 STRs with blood DNA and their matched LCL DNA
samples from 6645 unrelated healthy individuals.
Results: Mutations (such as repeat variations and triallelic patterns) of 15 STR
loci were detected in 612 LCL DNAs (9.2% of total) without mutations in their
matched blood DNA. The repeat variations of 15 STRs were detected in 526 LCL
DNAs (mutation rate Z 0.0792) and triallelic patterns were identified in 123
(mutation rate Z 0.0185). Among 15 STRs, the most common repeat variations
(n Z 214, mutation rate Z 0.0322) and triallelic patterns (n Z 17, mutation
rate Z 0.0026) were found at FGA locus.
Conclusion: Our study shows that mutations in STRs can occur during generation
and immortalization of LCLs.1. Introduction
EpsteineBarr virus (EBV)-transformed lympho-
blastoid cell lines (LCLs) are a biological resource that
is widely used in various research fields such as
human genetics, immunology, pharmacogenomics, and
toxicogenomics. Screening for toxicological effects ofted under the terms of the
) which permits unrestrict
operly cited.
is paper.
ase Control and Preventionenvironmental toxicants and drugs using animal models
or humans has concerns including high cost burden,
time-consuming tasks, bioethics, and safety [1]. For this
reason, many animal cell models have been widely used
for pharmacological and toxicological research. LCLs
are a model system that can assess various toxicants and
drug-induced toxicity, as well as study the genetics ofCreative Commons Attribution Non-Commercial License (http://
ed non-commercial use, distribution, and reproduction in any
. Published by Elsevier Korea LLC. All rights reserved.
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being able to provide an unlimited DNA or RNA source
for identification of disease-associated genetic factors
[2]. For example, LCL samples from Parkinson’s dis-
ease patients were used to identify mutation of parkin
(PRKN) [3] and DJ-1 [4] genes. With the development
of next-generation sequencing technology, whole
genome and exome sequencing has been carried out
using a large number of LCL samples [5].
LCLs are generated by a transformation process by
which human B lymphocytes are infected with EBV.
Thus, genomic alterations can occur in LCLs during
their generation and immortalization processes, but little
is known about the genomic instability in LCLs. Pre-
vious studies showed genomic variations in LCLs
compared to their matched blood samples through
genome-wide single nucleotide polymorphism (SNP)
analysis [6,7]. Copy number variation was observed in
LCLs [8]. Genomic alterations in LCLs are minimal,
however, these can influence the results of genome-wide
association studies [6].
In this study, we identified genomic alterations in
LCLs compared with their matched blood samples,
using short tandem repeats (STRs) analysis.2. Materials and Methods
2.1. Population
The National Biobank of Korea has collected a large
number of DNA samples and performed STR analysis
for quality control of DNA samples. For this study, we
used STR data of blood DNA and matched LCL DNA
from 6645 unrelated healthy individuals of the Ansan
and Ansung cohort in Korea.Table 1. Mutation data of STRs analyzed from blood and LCL
STR markers
Repeat variations at STRs
Number of LCLs with mutations Mutation
D8S1179 165 0.024
D21S11 159 0.023
D7S820 186 0.028
CSF1PO 163 0.024
D3S1358 147 0.022
TH01 150 0.022
D13S317 182 0.027
D16S539 174 0.026
D2S1338 182 0.027
D5S818 161 0.024
FGA 214 0.032
D19S433 196 0.029
vWA 170 0.025
TPOX 124 0.018
D18S51 194 0.029
Total 526 0.079
LCL Z lymphoblastoid cell line; STR Z single tandem repeat.2.2. DNA extraction
Genomic DNA was isolated with blood and LCL
samples from 6645 individuals using Gentra Puregene
Blood kit (Qiagen, Chatsworth, CA, USA) in accor-
dance with the manufacturer’s instructions.
2.3. STR analysis
Multiplex polymerase chain reaction for 15 STR loci
(CSF1P0, D2S1338, D3S1358, D5S818, D7S820,
D8S1179, D13S317, D16S539, D18S51, D19S433,
D21S11, FGA, TH01, TPOX, and vWA) and ameloge-
nin, the gender marker, was performed with genomic
DNA using the AmpFlSTR Identifiler (Applied Bio-
systems, Foster City, CA, USA) commercial kit,
following the user’s manual. PCR amplicons were
separated and genotyped using the ABI PRISM 3730
DNA Analyzer (Applied Biosystems) and all allele
fragment sizes were determined using GeneMapper ID
3.2 software.3. Results
We analyzed 15 STRs (CSF1P0, D2S1338,
D3S1358, D5S818, D7S820, D8S1179, D13S317,
D16S539, D18S51, D19S433, D21S11, FGA, TH01,
TPOX, and vWA) in blood DNA and matched LCL
DNA from 6645 individuals. Through comparative
analysis of STR data in blood and LCL DNA, we
identified mutations of 15 STR loci in 612 LCL DNAs
(9.2% of total) without mutations in their matched blood
DNA. These mutations included repeat variations (such
as single- or multi-repeat changes and repeat gains or
losses) and triallelic patterns of STRs. The repeatDNA samples of 6645 individuals
Triallelic patterns at STRs
rate Number of LCLs with mutations Mutation rate
8 14 0.0021
9 12 0.0018
0 6 0.0009
5 10 0.0015
1 2 0.0003
6 1 0.0002
4 3 0.0005
2 4 0.0006
4 6 0.0009
2 8 0.0012
2 17 0.0026
5 8 0.0012
6 16 0.0024
7 5 0.0008
2 17 0.0026
2 123 0.0185
196 J.-E. Lee, et alvariations were observed in 526 LCL DNAs (mutation
rate Z 0.0792) and triallelic patterns were identified in
123 (mutation rateZ 0.0185) (Table 1). Thirty-seven of
all LCL DNAs with triallelic patterns also showed the
repeat variations. STR data of 86 LCL DNAs showed
triallelic patterns without repeat variations. Among 15
STRs, the most common repeat variations (n Z 214,
mutation rateZ 0.0322) and triallelic patterns (nZ 17,
mutation rate Z 0.0026) were found at FGA locus.4. Discussion
Instability of genomic DNA can occur in LCLs
through EBV transformation during generation and
immortalization. Genomic alterations in LCLs have
been confirmed using various genome analysis tools
such as SNP genotyping and copy number variation
analysis [6e8]. Chromosomal abnormalities were iden-
tified in 30 of 268 LCLs from the HapMap project using
karyotyping and SNP genotyping [8]. Chromosomes 9,
12, and X displayed a tendency toward trisomy, in
particular. Furthermore, somatic deletions were detected
in LCLs from father/motherechild pairs when SNP
genotyping was performed after removing these
abnormal chromosomes.
In this study,we identifiedmutations (including single-
or multi-repeat changes, repeat gains or losses, and tri-
allelic patterns) of 15 STR loci in 612 of 6645 LCLDNAs
(9.2%) via comparative analysis with STR data of blood
DNA and matched LCL DNA from 6645 unrelated
healthy individuals. In previous, somatic mutations were
investigated with DNA samples from 1,730e1,764 fa-
ther-son pairs which confirmed in paternity by various
DNAmarkers via Y-STRs analysis [9]. The 84 mutations
were identified in all 29,792 17 Y-STRs data of father-
eson pairs (mutation rateZ 0.0028). Triallelic patterns
of STRs were detected at D21S11 and FGA loci of pa-
tients with Down syndrome [10] and oral cancer [11],respectively. This showed that mutations of STRs can
happen in cell transformation processes, although the
mechanism is unknown. In conclusion, our data showed
that mutations of STRs can occur during generation and
immortalization of LCLs.
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